Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer DELANEY MARK E
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer SAMAD SAM
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer KUPPUSAMY KARTHIK
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer Plewman Patrick
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Gregg Vicky B
Quest Diagnostics | 10-Q: Q2 2024 Earnings Report
Quest Diagnostics | 144: Notice of proposed sale of securities pursuant to Rule 144
Quest Diagnostics | 8-K: Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Officer SAMAD SAM
Quest Diagnostics | 8-K: Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director RING TIMOTHY M
Quest Diagnostics | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Quest Diagnostics | 8-K: Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors
Quest Diagnostics | 8-K: Poll Results of 2024 Stockholders Meeting
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director CARTER ROBERT B
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director PFEIFFER GARY M
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director RING TIMOTHY M
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director MAIN TIMOTHY L
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Gregg Vicky B
Quest Diagnostics | 4: Statement of changes in beneficial ownership of securities-Director Lassiter Wright III
No Data